These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18591664)

  • 1. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex.
    Ueda K; Valdivia C; Medeiros-Domingo A; Tester DJ; Vatta M; Farrugia G; Ackerman MJ; Makielski JC
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9355-60. PubMed ID: 18591664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1-syntrophin mutations identified in sudden infant death syndrome cause an increase in late cardiac sodium current.
    Cheng J; Van Norstrand DW; Medeiros-Domingo A; Valdivia C; Tan BH; Ye B; Kroboth S; Vatta M; Tester DJ; January CT; Makielski JC; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):667-76. PubMed ID: 20009079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
    Hu RM; Tan BH; Orland KM; Valdivia CR; Peterson A; Pu J; Makielski JC
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(7):H994-H1001. PubMed ID: 23376825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption.
    Wu G; Ai T; Kim JJ; Mohapatra B; Xi Y; Li Z; Abbasi S; Purevjav E; Samani K; Ackerman MJ; Qi M; Moss AJ; Shimizu W; Towbin JA; Cheng J; Vatta M
    Circ Arrhythm Electrophysiol; 2008 Aug; 1(3):193-201. PubMed ID: 19684871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α1-Syntrophin Variant Identified in Drug-Induced Long QT Syndrome Increases Late Sodium Current.
    Choi JI; Wang C; Thomas MJ; Pitt GS
    PLoS One; 2016; 11(3):e0152355. PubMed ID: 27028743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.
    Cheng J; Valdivia CR; Vaidyanathan R; Balijepalli RC; Ackerman MJ; Makielski JC
    J Mol Cell Cardiol; 2013 Aug; 61():102-10. PubMed ID: 23541953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.
    Vatta M; Ackerman MJ; Ye B; Makielski JC; Ughanze EE; Taylor EW; Tester DJ; Balijepalli RC; Foell JD; Li Z; Kamp TJ; Towbin JA
    Circulation; 2006 Nov; 114(20):2104-12. PubMed ID: 17060380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
    Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
    Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel.
    Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL
    Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.
    Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG
    Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations.
    Wattanasirichaigoon D; Vesely MR; Duggal P; Levine JC; Blume ED; Wolff GS; Edwards SB; Beggs AH
    Am J Med Genet; 1999 Oct; 86(5):470-6. PubMed ID: 10508990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
    Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
    Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation.
    Tester DJ; Valdivia C; Harris-Kerr C; Alders M; Salisbury BA; Wilde AA; Makielski JC; Ackerman MJ
    Heart Rhythm; 2010 Jul; 7(7):912-9. PubMed ID: 20403459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients.
    Ruan Y; Liu N; Bloise R; Napolitano C; Priori SG
    Circulation; 2007 Sep; 116(10):1137-44. PubMed ID: 17698727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.
    Zhang T; Yong SL; Drinko JK; Popović ZB; Shryock JC; Belardinelli L; Wang QK
    Int J Cardiol; 2011 Mar; 147(2):239-45. PubMed ID: 19762097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.
    Huang H; Priori SG; Napolitano C; O'Leary ME; Chahine M
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H288-99. PubMed ID: 21076026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
    Tester DJ; Will ML; Haglund CM; Ackerman MJ
    Heart Rhythm; 2005 May; 2(5):507-17. PubMed ID: 15840476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.